{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:13:15Z","timestamp":1790190795860,"version":"4.1.0"},"reference-count":102,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2016-02184"],"award-info":[{"award-number":["2016-02184"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2014-02048"],"award-info":[{"award-number":["2014-02048"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003426","name":"G\u00f6ran Gustafssons Stiftelse f\u00f6r Naturvetenskaplig och Medicinsk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00213","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T04:37:01Z","timestamp":1583296621000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":43,"title":["Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine"],"prefix":"10.3389","volume":"11","author":[{"given":"Liis","family":"Sabre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanel","family":"Punga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rostedt","family":"Punga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies.","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.653","article-title":"Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries.","volume":"7","author":"Sabre","year":"2017","journal-title":"Brain Behav."},{"key":"B3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.","volume":"259","author":"Pevzner","year":"2012","journal-title":"J Neuro."},{"key":"B4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis.","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J Autoimmun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1212\/WNL.0000000000000478","article-title":"Anti-agrin autoantibodies in myasthenia gravis.","volume":"82","author":"Gasperi","year":"2014","journal-title":"Neurology."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091816","article-title":"Autoantibodies to agrin in myasthenia gravis patients.","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One."},{"key":"B8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms.","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/nyas.13519","article-title":"Thymus involvement in early-onset myasthenia gravis.","volume":"1412","author":"Cron","year":"2018","journal-title":"Ann N Y Acad Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/ene.12359","article-title":"EFNS\/ENS guidelines for the treatment of ocular myasthenia.","volume":"21","author":"Kerty","year":"2014","journal-title":"Eur J Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1586\/eci.12.34","article-title":"Muscle autoantibodies in myasthenia gravis: beyond diagnosis?","volume":"8","author":"Meriggioli","year":"2012","journal-title":"Exp Rev Clin Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/mus.23330","article-title":"Recommendations for myasthenia gravis clinical trials.","volume":"45","author":"Benatar","year":"2012","journal-title":"Muscle Nerve."},{"key":"B13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1749-6632.2012.06787.x","article-title":"Biomarker development for myasthenia gravis.","volume":"1275","author":"Kaminski","year":"2012","journal-title":"Ann N Y Acad Sci."},{"key":"B14","year":"2016","journal-title":"BEST (Biomarkers, EndpointS, and other Tools) Resource."},{"key":"B15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.","volume":"75","author":"Lee","year":"1993","journal-title":"Cell."},{"key":"B16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2217\/fvl.13.19","article-title":"Old and new functions for the adenovirus virus-associated RNAs.","volume":"8","author":"Punga","year":"2013","journal-title":"Future Virol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/genes1010070","article-title":"Next generation sequencing of miRNAs - strategies, resources and methods.","volume":"1","author":"Motameny","year":"2010","journal-title":"Genes (Basel)."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1093\/nar\/gkz097","article-title":"An estimate of the total number of true human miRNAs.","volume":"47","author":"Alles","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1261\/rna.068692.118","article-title":"Post-transcriptional control of miRNA biogenesis.","volume":"25","author":"Michlewski","year":"2019","journal-title":"RNA."},{"key":"B20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/s0092-8674(03)00801-8","article-title":"Functional siRNAs and miRNAs exhibit strand bias.","volume":"115","author":"Khvorova","year":"2003","journal-title":"Cell."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0030085","article-title":"Principles of microRNA-target recognition.","volume":"3","author":"Brennecke","year":"2005","journal-title":"PLoS Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/cdd.2009.105","article-title":"MicroRNAs as regulators of death receptors signaling.","volume":"17","author":"Garofalo","year":"2010","journal-title":"Cell Death Differ."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-017-0551-0","article-title":"microRNAs: important regulators of stem cells.","volume":"8","author":"Li","year":"2017","journal-title":"Stem Cell Res Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.autrev.2016.09.003","article-title":"The role of microRNAs in the pathogenesis of autoimmune diseases.","volume":"15","author":"Chen","year":"2016","journal-title":"Autoimmun Rev."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2005825","article-title":"Dysregulation of microRNA biogenesis and gene silencing in cancer.","volume":"8","author":"Hata","year":"2015","journal-title":"Sci Signal."},{"key":"B26","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/joim.12298","article-title":"The emerging role of microRNAs in cardiovascular disease.","volume":"276","author":"Maegdefessel","year":"2014","journal-title":"J Intern Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1373\/clinchem.2007.097972","article-title":"Detection and characterization of placental microRNAs in maternal plasma.","volume":"54","author":"Chim","year":"2008","journal-title":"Clin Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1365-2141.2008.07077.x","article-title":"Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.","volume":"141","author":"Lawrie","year":"2008","journal-title":"Br J Haematol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection.","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B31","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat Cell Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","article-title":"The microRNA spectrum in 12 body fluids.","volume":"56","author":"Weber","year":"2010","journal-title":"Clin Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1093\/nar\/gkr254","article-title":"Characterization of extracellular circulating microRNA.","volume":"39","author":"Turchinovich","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ncb1800","article-title":"Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.","volume":"10","author":"Skog","year":"2008","journal-title":"Nat Cell Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3402\/jev.v3.24641","article-title":"Routes and mechanisms of extracellular vesicle uptake.","volume":"3","author":"Mulcahy","year":"2014","journal-title":"J Extracell Vesicles."},{"key":"B36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis.","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1285","article-title":"Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells.","volume":"2","author":"Mittelbrunn","year":"2011","journal-title":"Nat Commun."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3980","article-title":"Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs.","volume":"4","author":"Villarroya-Beltri","year":"2013","journal-title":"Nat Commun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cmet.2019.07.011","article-title":"Extracellular miRNAs: from biomarkers to mediators of physiology and disease.","volume":"30","author":"Mori","year":"2019","journal-title":"Cell Metab."},{"key":"B40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2217\/epi-2018-0183","article-title":"Circulating miRNAs as mediators in cell-to-cell communication.","volume":"11","author":"Bar","year":"2019","journal-title":"Epigenomics."},{"key":"B41","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1373\/clinchem.2012.195776","article-title":"Targeting the circulating microRNA signature of obesity.","volume":"59","author":"Ortega","year":"2013","journal-title":"Clin Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1530\/EJE-14-0867","article-title":"Elevated circulating microRNA-122 is associated with obesity and insulin resistance in young adults.","volume":"172","author":"Wang","year":"2015","journal-title":"Eur J Endocrinol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1055\/a-0824-4813","article-title":"MicroRNA profile and adaptive response to exercise training: a review.","volume":"40","author":"Domanska-Senderowska","year":"2019","journal-title":"Int J Sports Med."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s12263-015-0483-1","article-title":"Use of miRNAs in biofluids as biomarkers in dietary and lifestyle intervention studies.","volume":"10","author":"Rome","year":"2015","journal-title":"Genes Nutr."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/731479","article-title":"Challenges in using circulating miRNAs as cancer biomarkers.","volume":"2015","author":"Tiberio","year":"2015","journal-title":"Biomed Res Int."},{"key":"B46","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jcmm.12236","article-title":"Methodological challenges in utilizing miRNAs as circulating biomarkers.","volume":"18","author":"Moldovan","year":"2014","journal-title":"J Cell Mol Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1373\/clinchem.2014.221341","article-title":"Circulating microRNA biomarker studies: pitfalls and potential solutions.","volume":"61","author":"Witwer","year":"2015","journal-title":"Clin Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/acn3.24","article-title":"Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker.","volume":"1","author":"Punga","year":"2014","journal-title":"Ann Clin Transl Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jns.2015.06.019","article-title":"Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients.","volume":"356","author":"Punga","year":"2015","journal-title":"J Neurol Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis.","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000450","article-title":"Thymectomy lowers the myasthenia gravis biomarker miR-150-5p.","volume":"5","author":"Molin","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113842","article-title":"Ectopic microRNA-150-5p transcription sensitizes glucocorticoid therapy response in MM1S multiple myeloma cells but fails to overcome hormone therapy resistance in MM1R cells.","volume":"9","author":"Palagani","year":"2014","journal-title":"PLoS One."},{"key":"B53","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/mus.25493","article-title":"Physical exercise in myasthenia gravis is safe and improves neuromuscular parameters and physical performance-based measures: a pilot study.","volume":"56","author":"Westerberg","year":"2017","journal-title":"Muscle Nerve."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091927","article-title":"Analysis of serum miRNA profiles of myasthenia gravis patients.","volume":"9","author":"Nogales-Gadea","year":"2014","journal-title":"PLoS One."},{"key":"B55","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nyas.13563","article-title":"Challenging the current model of early-onset myasthenia gravis pathogenesis in the light of the MGTX trial and histological heterogeneity of thymectomy specimens.","volume":"1413","author":"Weis","year":"2018","journal-title":"Ann N Y Acad Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jneuroim.2018.05.003","article-title":"Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis.","volume":"321","author":"Sabre","year":"2018","journal-title":"J Neuroimmunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/nyas.13510","article-title":"Circulating microRNAs as potential biomarkers in myasthenia gravis patients.","volume":"1412","author":"Punga","year":"2018","journal-title":"Ann N Y Acad Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis.","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle Nerve."},{"key":"B59","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.nrl.0000240856.03505.b5","article-title":"Ocular myasthenia: diagnosis, treatment, and pathogenesis.","volume":"12","author":"Kusner","year":"2006","journal-title":"Neurologist."},{"key":"B60","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/WNO.0000000000000350","article-title":"Ocular myasthenia gravis: toward a risk of generalization score and sample size calculation for a randomized controlled trial of disease modification.","volume":"36","author":"Wong","year":"2016","journal-title":"J Neuroophthalmol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/acn3.692","article-title":"miR\u221230e\u22125p as predictor of generalization in ocular myasthenia gravis.","volume":"6","author":"Sabre","year":"2019","journal-title":"Ann Clin Transl Neurol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/00041327-200312000-00001","article-title":"Does early immunotherapy reduce the conversion of ocular myasthenia gravis to generalized myasthenia gravis?","volume":"23","author":"Kupersmith","year":"2003","journal-title":"J Neuroophthalmol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1007\/s00415-009-5120-8","article-title":"Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up.","volume":"256","author":"Kupersmith","year":"2009","journal-title":"J Neurol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1684\/ecn.2015.0367","article-title":"Disease-specific signature of serum miR-20b and its targets IL-8 and IL-25, in myasthenia gravis patients.","volume":"26","author":"Chunjie","year":"2015","journal-title":"Eur Cytokine Netw."},{"key":"B65","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nyas.13518","article-title":"Myasthenia gravis with antibodies to MuSK: an update.","volume":"1412","author":"Evoli","year":"2018","journal-title":"Ann N Y Acad Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jneuroim.2016.01.003","article-title":"Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis.","volume":"292","author":"Punga","year":"2016","journal-title":"J Neuroimmunol."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041561","article-title":"Comparing the MicroRNA spectrum between serum and plasma.","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One."},{"key":"B68","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2018.10.003","article-title":"Circulating microRNA plasma profile in MuSK+ myasthenia gravis.","volume":"325","author":"Sabre","year":"2018","journal-title":"J Neuroimmunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.21873\/anticanres.12107","article-title":"MiRNA-210: a current overview.","volume":"37","author":"Bavelloni","year":"2017","journal-title":"Anticancer Res."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22844-2","article-title":"Bone-related circulating MicroRNAs miR-29b-3p, miR-550a-3p, and miR-324-3p and their association to bone microstructure and histomorphometry.","volume":"8","author":"Feichtinger","year":"2018","journal-title":"Sci Rep."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/imm.12367","article-title":"Immuno-miRs: critical regulators of T-cell development, function and ageing.","volume":"144","author":"Kroesen","year":"2015","journal-title":"Immunology."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00430","article-title":"Ectopic lymphoid structures: powerhouse of autoimmunity.","volume":"7","author":"Corsiero","year":"2016","journal-title":"Front Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"7080","DOI":"10.1073\/pnas.0702409104","article-title":"miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely.","volume":"104","author":"Zhou","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B74","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/cmi.2011.27","article-title":"MicroRNAs are key regulators controlling iNKT and regulatory T-cell development and function.","volume":"8","author":"Zhou","year":"2011","journal-title":"Cell Mol Immunol."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075348","article-title":"Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation.","volume":"8","author":"de Candia","year":"2013","journal-title":"PLoS One."},{"key":"B76","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ana.23880","article-title":"Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.","volume":"73","author":"Gandhi","year":"2013","journal-title":"Ann Neurol."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095920","article-title":"MicroRNA-150 is a potential biomarker of HIV\/AIDS disease progression and therapy.","volume":"9","author":"Munshi","year":"2014","journal-title":"PLoS One."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1136\/gutjnl-2011-301122","article-title":"miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.","volume":"61","author":"Ma","year":"2012","journal-title":"Gut."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00539","article-title":"Causes and consequences of miR-150-5p dysregulation in myasthenia gravis.","volume":"10","author":"Cron","year":"2019","journal-title":"Front Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2119\/molmed.2014.00214","article-title":"Opposite prognostic significance of cellular and serum circulating microRNA-150 in patients with chronic lymphocytic leukemia.","volume":"21","author":"Stamatopoulos","year":"2015","journal-title":"Mol Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/art.30131","article-title":"MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjogren\u2019s syndrome.","volume":"63","author":"Alevizos","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193157","article-title":"Circulating small non-coding RNAs reflect IFN status and B cell hyperactivity in patients with primary Sjogren\u2019s syndrome.","volume":"13","author":"Lopes","year":"2018","journal-title":"PLoS One."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1186\/ar4131","article-title":"MicroRNA control in the development of systemic autoimmunity.","volume":"15","author":"Hu","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076217","article-title":"Dual role of miR-21 in CD4+ T-cells: activation-induced miR-21 supports survival of memory T-cells and regulates CCR7 expression in naive T-cells.","volume":"8","author":"Smigielska-Czepiel","year":"2013","journal-title":"PLoS One."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1136\/ard.2010.139857","article-title":"Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.","volume":"70","author":"Stagakis","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/tan.12874","article-title":"Circulating hsa-miR-30e-5p, hsa-miR-92a-3p, and hsa-miR-223-3p may be novel biomarkers in systemic lupus erythematosus.","volume":"88","author":"Kim","year":"2016","journal-title":"HLA."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.356","article-title":"miR-30e reciprocally regulates the differentiation of adipocytes and osteoblasts by directly targeting low-density lipoprotein receptor-related protein 6.","volume":"4","author":"Wang","year":"2013","journal-title":"Cell Death Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1101\/gad.215376.113","article-title":"Let-7 represses Nr6a1 and a mid-gestation developmental program in adult fibroblasts.","volume":"27","author":"Gurtan","year":"2013","journal-title":"Genes Dev."},{"key":"B89","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.stemcr.2014.08.015","article-title":"let-7 miRNAs can act through notch to regulate human gliogenesis.","volume":"3","author":"Patterson","year":"2014","journal-title":"Stem Cell Reports."},{"key":"B90","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/gene.2010.53","article-title":"Let-7\/miR-98 regulate Fas and Fas-mediated apoptosis.","volume":"12","author":"Wang","year":"2011","journal-title":"Genes Immun."},{"key":"B91","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/ni.3036","article-title":"TLR7 induces anergy in human CD4(+) T cells.","volume":"16","author":"Dominguez-Villar","year":"2015","journal-title":"Nat Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.imlet.2016.02.005","article-title":"Altered expression of miR-125a-5p in thymoma-associated myasthenia gravis and its down-regulation of foxp3 expression in Jurkat cells.","volume":"172","author":"Li","year":"2016","journal-title":"Immunol Lett."},{"key":"B93","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.autrev.2018.01.008","article-title":"Analysis of microRNA expression in the thymus of Myasthenia Gravis patients opens new research avenues.","volume":"17","author":"Cron","year":"2018","journal-title":"Autoimmun Rev."},{"key":"B94","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/nyas.13573","article-title":"Agrin and LRP4 antibodies as new biomarkers of myasthenia gravis.","volume":"1413","author":"Yan","year":"2018","journal-title":"Ann N Y Acad Sci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.intimp.2012.07.003","article-title":"Altered let-7 expression in Myasthenia gravis and let-7c mediated regulation of IL-10 by directly targeting IL-10 in Jurkat cells.","volume":"14","author":"Jiang","year":"2012","journal-title":"Int Immunopharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10875-012-9834-5","article-title":"MiR-320a is downregulated in patients with myasthenia gravis and modulates inflammatory cytokines production by targeting mitogen-activated protein kinase 1.","volume":"33","author":"Cheng","year":"2013","journal-title":"J Clin Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.neulet.2013.09.014","article-title":"Altered expression of miR-146a in myasthenia gravis.","volume":"555","author":"Lu","year":"2013","journal-title":"Neurosci Lett."},{"key":"B98","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.clim.2015.12.009","article-title":"MiR-15a contributes abnormal immune response in myasthenia gravis by targeting CXCL10.","volume":"164","author":"Liu","year":"2016","journal-title":"Clin Immunol."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201848007","article-title":"MiR-181a regulates CD4(+) T cell activation and differentiation by targeting IL-2 in the pathogenesis of myasthenia gravis.","author":"Liu","year":"2019","journal-title":"Eur J Immunol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10238-015-0358-1","article-title":"Decreased microRNA miR-181c expression in peripheral blood mononuclear cells correlates with elevated serum levels of IL-7 and IL-17 in patients with myasthenia gravis.","volume":"16","author":"Zhang","year":"2016","journal-title":"Clin Exp Med."},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104388","article-title":"MicroRNA signature associated with treatment response in myasthenia gravis: a further step towards precision medicine.","volume":"148","author":"Cavalcante","year":"2019","journal-title":"Pharmacol Res."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205464","article-title":"MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis.","volume":"13","author":"Sengupta","year":"2018","journal-title":"PLoS One."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00213\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T04:37:04Z","timestamp":1583296624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00213\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":102,"alternative-id":["10.3389\/fimmu.2020.00213"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00213","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]},"article-number":"213"}}